Scientific Updates for the Advanced Management of Idiopathic Pulmonary Fibrosis

http://academiccme.com/wp-content/uploads/2018/12/CHEST-Image--wpcf_400x400.jpg

Course Information

Therapautic Area: Pulmonolgy
Format(s): Post Conference Review and Analysis
Credit(s): 1.0 AMA PRA Category 1 Credit™; 1.0 CNE contact hour
Activity Dates: December 14, 2018 - December 13, 2019

 

Program Overview

This CME/CNE program will outline recent advances in the treatment and management of  idiopathic pulmonary fibrosis (IPF), incorporating data presented at the 2018 American College of Chest Physicians (CHEST) Annual Meeting in San Antonio, Texas. Three expert faculty, led by Dr. Fernando Martinez, will review and compare recent guidelines/criteria as it relates to therapeutic decision making in the IPF landscape. Current clinical trial data of both emerged and emerging agents will be analyzed and their clinical relevance will be debated. The expert faculty will relay best practices for utilizing a team-based approach to supportive care to improve patient outcomes and quality of life. At the conclusion of this educational activity, learners will be better acquainted with optimal treatment, monitoring and management techniques for patients with idiopathic pulmonary fibrosis.

Target Audience

Pulmonologists, internists, nurse practitioners, nurses, and other healthcare professionals involved in the management of patients with IPF

Learning Objectives

1. Identify early stages, as well as, associated comorbidities of IPF 2. Organize the latest data of current and emerging therapeutic options for the treatment of IPF, incorporating data presented at CHEST 2018 3. Implement evidence-based data into individualized, interprofessional treatment strategies to improve outcomes and the overall quality of life in patients with IPF

Faculty

Martinez HeadshotFernando J. Martinez, MD (Course Chair)
Executive Vice Chair of Medicine
Weill Cornell Medical Center
New York City, New York

 

 

Kaner HeadshotRobert J. Kaner, MD
New York-Presbyterian/Weill Cornell Medical Center
Associate Professor of Clinical Medicine and Genetic Medicine
Weill Cornell Medicine
New York City, New York

 

 

Alanna-Kendig-FinalAlanna Kavanaugh, MSN, FNP-BC, CCRN
Nurse Practitioner
Weill Cornell Medical Center
Professor of Clinical Practice
College of Mount Saint Vincent
New York City, New York  

Disclosures of Conflict of Interest

It is the policy of AcademicCME that all faculty, instructors, and planners disclose real or apparent conflicts of interest relating to the topics of this educational activity. The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CNE activity:

Faculty Relationship Identified With:
Fernando J. Martinez, MD Consultant/Advisor: AstraZeneca; Bayer AG; Biogen; Boehringer Ingelheim Pharmaceuticals, Inc.; Bridge Therapeutics; Chiesi USA, Inc.; GlaxoSmithKline; Nitto Pharmaceutical Industries, Ltd.; ProMedior, Inc.; Prometic Life Sciences Inc.; ProterixBio, Inc.; Sunovion Pharmaceuticals Inc.; Teva Pharmaceutical Industries Ltd.; Veracyte, Inc.Grant/Research Support: Biogen; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd; Genentech, Inc.
Robert J. Kaner, MD Consultant/Advisor: Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd; Genentech, Inc.Grant/Research Support: Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd; Genentech, Inc.Speaker’s Bureau: Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd; Genentech, Inc.
Alanna Kavanaugh, MSN, FNP-BC, CCRN Nothing to disclose.

Planners, Managers, Reviewers

Timothy Hayes, MD, PhD; Emma Boring; Nicole Brestowski and Kim Cheramie, MSN, RN-BC hereby state that they or their spouse/life partner do not have any financial relationships to products or devices with any commercial interests related to the content of this activity of any amount during the past 12 months.

Accreditation Statement

In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Screen Shot 2018-12-11 at 12.19.42 PM

Credit Designation Statements

AcademicCME designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AcademicCME designates this enduring material for a maximum of 1.0 CNE contact hour (1.0 CNE pharmacotherapeutic contact hour).

Financial Support

This activity has been supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. AcademicCME and Boehringer Ingelheim Pharmaceuticals, Inc. do not recommend the use of any agent outside of the labeled indications.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Method of Participation

  1. Read the learning objectives, accreditation information and faculty disclosures at the beginning of this activity.
  2. Complete the Pre-Activity Questions.
  3. Read or Review the activity content.
  4. Complete the Post-Activity Test Questions and Evaluation.
  5. Healthcare providers who receive a grade of 70% or better on the Post-Activity Test Questions and who complete the Evaluation will receive a CME/CNE Certificate.
  6. All other participants who receive a grade of 70% or better on the Post-Activity Test Questions and who complete the Evaluation will receive a Certificate of Participation.
  7. Healthcare providers should claim only the credit commensurate with the extent of their participation in the activity.
  8. 60 minutes of participation = 1 CNE contact hour

CE Inquiries/Special Needs

For all CME/CNE inquiries or special needs, please contact admin@academiccme.com.

BUTTON


Provided by AcademicCME AcademicCME-web